Wordt geladen...
New Medications in the Treatment of Hereditary Transthyretin Amyloidosis
Hereditary transthyretin amyloidosis is an inherited disorder that results in the gradual progressive deposit of abnormal protein called amyloid in the body’s organs and tissues. There are currently no approved drugs to treat transthyretin amyloidosis, and patients may require liver transplantation...
Bewaard in:
| Gepubliceerd in: | Hosp Pharm |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6050879/ https://ncbi.nlm.nih.gov/pubmed/30038442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578718779757 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|